Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma

[1]  P. Boyle,et al.  World Cancer Report 2008 , 2009 .

[2]  P. Guan,et al.  XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers. , 2008, Lung cancer.

[3]  R. Ankathil,et al.  Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India , 2008, Journal of Cancer Research and Clinical Oncology.

[4]  Z. Dlamini,et al.  Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets. , 2007, International immunopharmacology.

[5]  Zhou Bao-sen,et al.  Relationship between ERCC2 polymorphism and risk of lung cancer in Chinese nonsmoker , 2007 .

[6]  H. Thierens,et al.  Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. , 2007, Mutation research.

[7]  G. Scagliotti,et al.  Prospective Assessment of XPD Lys751Gln and XRCC1 Arg399Gln Single Nucleotide Polymorphisms in Lung Cancer , 2007, Clinical Cancer Research.

[8]  Peng Liu,et al.  Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. , 2007, Lung cancer.

[9]  J. Minna,et al.  A Translational View of the Molecular Pathogenesis of Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  J. Ajani,et al.  Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Stephen J Chanock,et al.  Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer , 2006, Expert review of molecular diagnostics.

[12]  D. Campa,et al.  Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. , 2006, Carcinogenesis.

[13]  P. Brennan,et al.  Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. , 2005, American journal of epidemiology.

[14]  Rolf Lewensohn,et al.  The role of p53 in treatment responses of lung cancer. , 2005, Biochemical and biophysical research communications.

[15]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[16]  M. Taron,et al.  Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  D. Neuberg,et al.  Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy , 2004, Clinical Cancer Research.

[18]  D. Neuberg,et al.  XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Youngchul Kim,et al.  Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. , 2004, Lung cancer.

[20]  Stephen Abrahamson,et al.  An interview of Professor Stephen Abrahamson. , 2003, Education for health.

[21]  Guilbert Jj.  The world health report 2002 - reducing risks, promoting healthy life. , 2003 .

[22]  D. Christiani,et al.  Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  P Vineis,et al.  XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. , 2001, Carcinogenesis.

[24]  U. Vogel,et al.  DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. , 2000, Mutation research.

[25]  M. Spitz,et al.  Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. , 2000, Journal of the National Cancer Institute.

[26]  S. Z. Abdel‐Rahman,et al.  The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. , 2000, Cancer letters.

[27]  M. Spitz,et al.  Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. , 2000, Carcinogenesis.

[28]  B. Levin,et al.  DNA repair: a double-edged sword. , 2000, Journal of the National Cancer Institute.

[29]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[30]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[31]  N. Rothman,et al.  Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. , 2005, Anticancer research.

[32]  J. Guilbert.  The world health report 2002 - reducing risks, promoting healthy life. , 2003, Education for health.

[33]  P. Tamboli,et al.  Pathologic Evaluation of Lung Cancer , 2003 .

[34]  C. H. Kim,et al.  Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.